That's crucial, since the method a protein in the human body folds figures out if a pharmaceutical will have the ability to bind to that protein and be effective. To put it simply, we need to know how these proteins fold if we want a drug to work. Historically, this has actually been a trial-and-error process (jeff brown genetic sequencer stock). And now, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're designed to do. This was a breakthrough practically no one observed. However it's going to have profound implications for treating disease. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, of course, there will be lots of investment opportunities in this area, too. Moving topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (longtime readers). That said, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be amazed if it pulled back maybe significantly before going higher - angel investor. I have actually been covering bitcoin for a long time now. Among the first research study reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary recommendation, I titled my report "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time. We were primarily informing readers. However that's not the huge concern any longer. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. Mass, Mutual is a relied on 170-year-old organization. So consider that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a big factor I'm bullish on it this year. biotech stock. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These companies raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I predict 2021 will be another record year in IPOs. There are many terrific private business on the verge of striking the general public markets And I've been working on a new method for you to invest even prior to these companies go public.
This chance has actually been building over the last couple of years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to learn all the details. Go right here to schedule your area totally free.
Emma Walsh here, handling editor of the Journal. Routine Journal readers understand that tech isn't our normal beat (the legacy report predictions). And when it pertains to tech investing, we leave it to the experts. Fortunately, we have numerous such professionals in our Rolodex. Our associate Jeff Brown will be familiar to our longtime readers. He is among the most accomplished tech investing specialists we understand (diplomatic relations). In fact, he had a number of triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take a look at the huge photo and anticipate what's simply around the corner.
That includes things like 5G networks, biotech, artificial intelligence, and a lot more. These trends are experiencing exponential growth and producing unbelievable chances for financiers. I wish to make certain all our readers are prepared for what's next. And with that in mind, let me draw the image of what I see can be found in the next 12 months Our new 5G (fifth-generation) cordless networks are a topic I have actually been covering for years now. jeff brown stock picks 2021. However regardless of what many readers may think, this is a trend that's simply getting going. Even though the COVID-19 pandemic interrupted supply chains last year, an excellent 250 million 5G-enabled gadgets were still sold.
And all of this ultimately resulted in Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (white house). Losing two months of production and sales actually impacts the number of 5G gadgets are offered in the calendar year. When you think about all of that, selling 250 million systems is amazing. More importantly, the hold-ups caused by the pandemic created a heap of suppressed need. Which need is now going to be pushed into 2021. In fact, I anticipate that more than 500 million 5G gadgets will be shipped in 2021 - jeff brown predictions 2021. Which's not my only 5G forecast When I've discussed 5G in the past, I have actually explained its three various phases.
In Phase Two, 5G devices go on sale. 5G phones and other products start to reach consumers. And in Stage 3, 5G services start to be offered (korean actress). That's when we begin to see applications running on 5G networks. Consider things like enormous multiplayer video games over a smart phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will start Phase Three by this summertime. This begins something of a virtuous cycle: A lot of individuals don't truly care about the technology. However they will care if there are amazing applications that can only be accessed with a 5G phone.
That results in more 5G apps being developed. In truth, 5G is going to open up a suite of extraordinary applications: self-driving cars, the Internet of Things, robotic surgery, and more. All of these technologies require 5G. The investment opportunities moving forward will be massive. Stepping far from 5G, the next important innovation I foresee in 2021 is CRISPR genetic editing. CRISPR stands for "clustered regularly interspaced short palindromic repeat." It's a mouthful. But it's one of the most amazing advancements in biotechnology. At a high level, CRISPR is a technology that can edit our genetic makeup as if it were software application.
The program can crash or not operate correctly. CRISPR uses a similar concept however with our hereditary code. "Typos" in our genome can result in illness. CRISPR can correct these "typos." For many years, CRISPR was mostly a specific niche innovation that wasn't well comprehended. And throughout that time, there were really just three business running in this space. But things are changing. CRISPR is no longer simply theoretical. We're seeing real outcomes. We're dealing with illness and seeing that this innovation just works. And as an outcome, a "second crop" of early-stage CRISPR companies is going public and delivering incredible returns. This whole market is efficiently a greenfield chance.
There's room for many companies to exist in this space. jeff brown top stock pick 2021. And there will be more. That's my prediction for CRISPR in 2021. I predict that 2 or 3 more genetic editing business will hold their IPOs. Sticking to biotechnology, we are seeing incredible things occurring at the merging of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its most current Alpha, Fold software can precisely predict the folding of a protein based exclusively on its amino acid series with 92. 4% precision. That's essential due to the fact that the method a protein in the human body folds figures out if a pharmaceutical will have the ability to bind to that protein and be effective.
Historically, this has actually been a trial-and-error procedure. Today, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're designed to do. And here's my next forecast. I predict that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one however numerous drug therapies produced utilizing this technology. This was among those breakthroughs that practically nobody noticed. However it's going to have extensive ramifications for curing disease. And, naturally, there will be lots of investment chances in this area, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be surprised if it pulled back perhaps substantially prior to going higher. I've been covering bitcoin for a long period of time now. Among the very first research study reports I ever published was on bitcoin - social media. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anyone who followed my suggestion. But at the time of that preliminary recommendation, I entitled my report, "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time.
However no one is asking that concern anymore. Now, we're seeing institutional cash finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. the legacy report prediction. Mass, Mutual is a 150-year-old institution. So think of that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more benefit forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and declares the info is up to date since February 2021, however we could not separately verify this claim. Offered Jeff Brown's past, he likely has a significant net worth, however we can't hammer down an accurate figure at this moment. Brown is best understood for his sage-like capability to select winning innovation stocks. He invested more than 25 years investigating innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience provides him an exceptional point of view on the marketplace. He's always on the hunt for new opportunities, and he shares much of his finest choices in the Future Report.
That's full marks, however it's not ridiculously reasoned. Brown has an outstanding credibility as a stock-picker, and he effectively forecasted a few of the most significant financial events of the previous 20 years. Although he does not appear to launch his choices to the general public, the service's success is a direct sign of Brown's stock-picking prowess. Nobody on Wall Street gets it best every time, but Jeff Brown's accurate predictions have actually earned him legions of devoted followers. That states a lot about his capability. The Near Future Report is published by Brownstone Research, a popular monetary research publisher. Brownstone Research study uses a number of research study services with a wide array of expertises - jeff brown genome sequencing.
The company is likewise associated with Bonner & Partners, another well-respected research study publisher - jeff brown biotech pick. On its site, Brownstone states its mission is to supply retail financiers with professional-grade research: "For too long, the finest financial investment research has not been offered to individual financiers. It has been usually reserved for investment banks, hedge funds, private equity, and high-net-worth customers. jeff brown prediction for 2021. The mission of Brownstone Research study is to make that kind of exclusive research available to any investors aiming to gain an edge in the marketplaces. The goal is easy to provide special and lucrative investment research discovered nowhere else." -Brownstone Research site excerpt from the Jeff Brown is the creator of Brownstone Research, and he likewise serves as the company's Chief Investment Analyst.
With Brown assisting the ship, Brownstone Research is a powerhouse publisher with lots to use its customers. After years of steady success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a family name throughout most of America. If you know even a bit about the market, you know that he has a reputation as a King Midas of sorts. angel investor. Whatever he touches relies on gold! Jeff is well aware of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge job.
In fact, Brown believes S.A.V. jeff brown predictions for 2021. might be "the biggest trend of the 2020s, and he's not alone. Take a look at these quotes from other widely known S.A.V. bulls: Elon's next huge act will be weding 2 advanced technologies: synthetic intelligence and electric cars. Musk hopes the mix will assist him establish the first fully-autonomous, self-driving cars and trucks ever. It's absolutely nothing except the automotive market's Holy Grail. As you understand, electric lorries and self-driving car stocks have been huge this year, however the Wall Street machine has actually been huge on hype without much tangible result. Despite an extreme increase in competitors over the past couple of years, Brown still believes Musk has the very best possibility of putting all of it together.
tech might be the magic string that ties it all together. S.A.V. stands for Shared Autonomous Vehicle, and it might be the future of transportation. Basically, this innovation would enable you to lease your automobile as a self-governing, self-driving taxi when you're not using it. You just leave the car and press a button on an app that tells the automobile to "sign up with the fleet." Next thing you know, you're relaxing on your couch while your automobile shuttles ride-sharers around town. Best of all, you get to keep a substantial portion of the earnings. It sounds outrageous, but it could be closed than you believe.